Press release
Alzheimer's Drugs Market is Estimated to Reach USD 8.56 Billion by 2030: Cognitive Market Research
Alzheimer's Drugs Market is Estimated to Reach USD 8.56 Billion by 2030: Cognitive Market Research
- Alzheimer's disease is a most common cause of dementia that affects a person's memory, thinking, and behaviour. It is a brain disorder that gradually destroys a person's ability to remember, reason, and carry out daily activities leads to shrink the brain cells to eventually die. Alzheimer's disease is the most common cause of dementia, accounting for 60-70% of all cases. There are several drugs that are commonly used to treat Alzheimer's disease. These drugs work by helping to regulate the levels of certain chemicals in the brain that are involved in memory and thinking. Cholinesterase inhibitors, NMDA receptor antagonists are the commonly used Alzheimer's drugs available in the market.
Summary:
- Global Alzheimer's Drugs market is Expected to reach at USD 8.56 Billion in 2030, Growing at 7.50% CAGR from 2023 to 2030.
To know more The Alzheimer's Drugs Market statistics click here: https://www.cognitivemarketresearch.com/alzheimers-drugs-market-report
Alzheimer's Drugs Market Dynamics:
- The risk of developing Alzheimer's disease increases with age. As the population continues to age, the number of people developing Alzheimer's disease is increasing. According to the World Health Organization, by 2050, the world's population of people aged 60 years and older will double (2.1 billion). And the number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. Therefore, increasing geriatric population worldwide expected to grow the Alzheimer's drugs market growth. In addition, developing and growing pharmaceutical industry coupled creates new opportunities to the Alzheimer's drugs market.
Global Alzheimer's Drugs Market Segmentation:
- Drug Class:
• Cholinesterase Inhibitors
• NMDA Receptor Antagonist
• Combination Drug
• Others
- Distribution Channel:
• Hospital Pharmacy
• Retail Pharmacy
• E-commerce
- Competitive Analysis for Alzheimer's Drugs Market:
• Eisai Co., Ltd.
• Novartis AG
• AbbVie Inc. (Allergan Plc.)
• Adamas Pharmaceuticals, Inc.
• H. Lundbeck A/S
• Biogen
• AC Immune
• F. Hoffmann La Roche Ltd.
• Daiichi Sankyo Company, Limited
• Johnson & Johnson Services, Inc.
• TauRx Pharmaceuticals Ltd.
• Pfizer Inc.
• Merck Sharp & Dohme Corp.
• AstraZeneca
Get free sample pages of latest published Alzheimer's Drugs Market Report: https://www.cognitivemarketresearch.com/alzheimers-drugs-market-report
Regional Analysis of Alzheimer's Drugs Market:
- Geographically, the global market is divided into North America, Europe, Asia Pacific, Latin America, and Middle-east Countries. North America region is further bifurcated into U.S., Canada, Mexico. The Europe region is further characterized into U.K., France, Germany, and Rest of Europe. Asia Pacific is further divided into China, Japan, India, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, and Rest of Latin America. Middle East & Africa region covers the UAE, South Africa, and Rest of MEA. North America holds significant share and expected to be the fastest growing region of the global Alzheimer's drugs market due to the increasing prevalence of Alzheimer among elderly population in the region.
Recent developments in the market:
• February 6, 2023
Leqembi and its lead developer, the Japanese pharmaceutical firm Eisai, receives accelerated approval from the Food and Drug Administration.
• July 8, 2021
Biogen and Eisai Co., Ltd. has announced the U.S. Food and Drug Administration (FDA) has approved an updated label for ADUHELM™ (aducanumab-avwa) injection 100 mg/mL solution.
• June 24, 2021
The U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation for donanemab, Eli Lilly and Company's investigational antibody therapy for Alzheimer's disease (AD).
Browse Here For Full TOC:
Table of Content (Revenue USD Edition), (Enquire about Volume/Consumption Edition Data)
Chapter 1 Industrial Insight and Market Scope
• 1.1 Global Alzheimers Drugs Industry Introduction
• 1.2 Objectives of the Study
• 1.3 USP of the Report
• 1.4 Who is this report for?
• 1.5 Designing of Market Scope
1.5.1 Alzheimers Drugs Market Segmentation
1.5.1 Alzheimers Drugs Market Regional Fragmentation
1.5.1 Alzheimers Drugs Market Players
• 1.6 Report Duration
Chapter 2 Research MethodologyReview Complete Research Methodology
Chapter 3 Executive Summary of Alzheimers Drugs Market
• 3.1 Global Alzheimers Drugs Market Size 2018 - 2030, (USD Million)
• 3.2 Global Alzheimers Drugs Market Statistics 2022: Snapshot
Chapter 4 Global Alzheimers Drugs Market Overview
Chapter 5 Competitive Analysis (Subject to Availability)
Chapter 6 Qualitative Analysis
Chapter 7 Company Profiling (Subject to Availability)
Chapter 8 Global Alzheimers Drugs Market by Type Segmentation Analysis (2018-2030)
Chapter 9 Global Alzheimers Drugs Market by Application Segmentation Analysis (2018-2030)
Chapter 10 Global Alzheimers Drugs Market Regional Analysis
Chapter 11 North America Alzheimers Drugs Market Outlook (2018 - 2030)
Chapter 12 Europe Alzheimers Drugs Market Outlook (2018 - 2030)
Chapter 13 Asia Pacific Alzheimers Drugs Market Outlook (2018 - 2030)
Chapter 14 Latin America Alzheimers Drugs Market Outlook (2018 - 2030)
Chapter 15 Middle East and Africa Alzheimers Drugs Market Outlook (2018 - 2030)
Chapter 16 Research Findings
To know more Alzheimer's Drugs Market TOC click here: https://www.cognitivemarketresearch.com/alzheimers-drugs-market-report#table_of_contents
Related Market:
• Neurological Disorder Drugs Market- https://www.cognitivemarketresearch.com/neurological-disorder-drugs-market-report
• Biopharmaceuticals Market- https://www.cognitivemarketresearch.com/biopharmaceuticals-market-report
• Antiaging products and services Market- https://www.cognitivemarketresearch.com/antiaging-products-and-services-market-report
• Dementia drugs Market- https://www.cognitivemarketresearch.com/dementia-drugs-market-report
𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Nicolas Shaw
Cognitive Market Research
20 N State Street,Chicago,
Illinois, 60602
United States
USA: +1 312-376-8303
Europe and UK: (+44) 20-8144-9523
Asia Pacific: (+852) 81930785
Email: sales@cognitivemarketresearch.com
Website: https://www.cognitivemarketresearch.com/about-us
About Cognitive Market Research Company :
Cognitive Market Research has evolved as one leading market research and consulting firm and it provides services across multiple domains. Cognitive Market Research gathers and analyzes data about customers, competitors, distributors, and other market actors and forces operational across the value chain. As a market research company, we follow a complete process of gathering information about the target market and end-use industries to verify the complete journey of the product or service in the global market. It helps our readers understand the demand and viability of their product/service and how it might perform in the real world and help them to build business strategies accordingly.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Alzheimer's Drugs Market is Estimated to Reach USD 8.56 Billion by 2030: Cognitive Market Research here
News-ID: 2945596 • Views: …
More Releases from Cognitive Market Research
Ultra Fine Copper Powder Market is estimated to grow at a CAGR of 7.1% during th …
Market Overview:
- The term "ultra-fine copper powder" refers to a finely divided type of copper that is distinguished by its exceedingly small particle size and large surface area. It is made using a variety of processes, such as mechanical grinding, electrolysis, and chemical precipitation. Ultra-fine copper powder typically has particles between a few nanometres and a few micrometers in size.
Summary:
- As per Cognitive Market Research, Global Ultra-Fine Copper…
Premium Branding and Status Symbol boosts the Global Metal Card Market: Cognitiv …
Market Overview:
- A metal card typically refers to a credit or debit card that is made from metal materials instead of traditional plastic. These cards are often associated with premium or high-end credit card offerings and are designed to provide a more luxurious and prestigious feel. Metal cards are usually made from materials such as stainless steel, titanium, or other alloys, which gives them a solid and durable construction.…
Slot Machines Market is projected to grow at a CAGR of 12.9% within the forecast …
Market Overview:
A slot machine is operated by inserting coins into a slot and by pulling down on a long handle. It features a set of spinning reels with various symbols on them. Players or individuals insert coins or tokens into the machine and then pull a lever or press a button to activate the reels. The earliest slot machine technology was created with mechanical reels powered by random number generators.…
Mechanical Seals Market is estimated to grow at a CAGR of 4.8% within the foreca …
Market Overview:
A mechanical seal is only a way to keep fluid inside a vessel usually pumps, mixers, etc. when a rotating shaft passes through a stationary housing or, on rare occasions, when the housing rotates around the shaft. Mechanical seals are devices used to prevent leakage between two components or systems that are connected by a rotating shaft. They are commonly used in pumps, compressors, mixers, and other equipment that…
More Releases for Alzheimer
Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion.
Data Bridge…
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly…
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is…
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,…
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports.
Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as…
